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ICAM-l directs migration and localization of interstitial leukocytes in
experimental glomerulonephritis. Recent studies of rat anti-GBM dis-
ease have demonstrated a functional role of the ICAM-1ILFA-1 inter-
action in the entry of leukocytes into the glomerulus and an association
between interstitial ICAM-1 expression, leukocyte infiltration and
tubulointerstitial damage. In the current study, we used immunogold
ultrastructural techniques to identify ICAM-l/LFA-l interactions in the
initiation of interstitial leukocyte infiltration during the first 24 hours of
rat accelerated anti-GBM disease. In normal rats, there was weak
constitutive ICAM-1 expression in the interstitium: on the endothelial
luminal surface of interstitial capillaries, venules and arterioles, on the
entire surface of interstitial fibroblast-like cells and confined to the
brush border of proximal tubules. As early as 1.5 hours after injection
of anti-GBM serum, there was a marked increase in the intensity of
ICAM-1 expression, most notably on capillary endothelium, fibroblast-
like cells and brush borders of proximal tubules, particularly in the
periglomerular/perihilar areas. Mononuclear leukocytes exhibiting
strong surface LFA-l (CD1 la and CD18) expression were seen adher-
ent to the endothelium of interstitial capillaries, with ICAM-1 and
LFA-l antigens present at sites of contact. In addition, mononuclear
cells migrating into the interstitium showed areas of close apposition to
interstitial fibroblast-like cells, and here ICAM-l and LFA-1 expression
were also prominent at the sites of contact. This is the first study to
demonstrate sites of ICAM.1/LFA-l interaction in mononuclear cell
migration and localization in glomerulonephritis. The results suggest
that up-regulation of periglomerular/peritubular capillary ICAM-1 ex-
pression is important for mononuclear cell entry into the interstitium,
while interaction with fibroblast-like cells may facilitate movement and
subsequent focal accumulation of mononuclear cells at sites within the
interstitium.
It is now well-recognized that most forms of glomerulone-
phritis have a significant interstitial mononuclear leukocytic
infiltrate which correlates better with the degree of renal
insufficiency than does the severity of the glomerular lesion
[1—5]. In experimental accelerated anti-glomerular basement
membrane glomerulonephntis (anti—GBM ON) interstitial leu-
kocytic infiltration becomes evident within 12 hours, initially in
a perivascular sheath surrounding glomerular hilar arterioles
and then becoming widespread to periglomerular and tubuloin-
terstitial areas [2].
It is now apparent that leukocyte entry into tissues is con-
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trolled by the dynamic interaction between adhesion molecules
expressed by leukocytes and the endothelium [6—9]. The inter-
cellular adhesion molecule-l (ICAM-1, CD54), a cell surface
glycoprotein belonging to the immunoglobulin superfamily, is
expressed on many cell types including endothelium [10] and is
up-regulated by proinflammatory cytokines (IL-i, TNF and y
IFN) [6, ii]. ICAM-1 plays a major role in T lymphocyte and
macrophage adhesion to activated endothelium via binding to
the ligand lymphocyte function-associated antigen-I (LFA-i)
[6, 8, 11—14]. LFA-1, a member of the (32 integrin family, is
made up of an a chain (CD1 la) and a /3 chain (CD18) and is
expressed on most leukocytes, particularly activated T cells [7,
151.
The functional importance of the ICAM-l/LFA-i interaction
in the leukocytic accumulation in rat anti-GBM GN has recently
been demonstrated by in vivo antibody blocking studies [16].
Furthermore, treatment of rat anti-GBM ON with the IL-i
receptor antagonist has demonstrated that up-regulation of
interstitial ICAM-l expression is associated with interstitial
leukocytic infiltration and tubulointerstitial damage (Nikolic-
Paterson et al, manuscript submitted).
A number of light microscopy studies have examined
ICAM-1 expression in renal diseases [17—26], but the exact
localization of ICAM-i in glomerulonephritis remains to be
established. Therefore the aim of this study was to determine
the precise ultrastructural localization of ICAM- 1 expression
and ICAM-i/LFA-l interactions during the initiation of the
interstitial leukocytic infiltration in anti-GBM ON in the rat.
Methods
Animals
Inbred male Sprague-Dawley (SD) rats aged three to four
months were obtained from the Monash Medical Centre Animal
House.
Experimental anti-GBM glomerulonephritis
Rabbit nephrotoxic serum (NTS) was raised as previously
described [21. Passive accelerated anti-GBM GN was induced
in SD rats by subcutaneous immunization with 5 mg of normal
rabbit IgG (Silenus, Australia) in Freund's adjuvant followed
five days later by intravenous injection of NTS (10 mtfkg body
wt). Groups of two animals were sacrificed at 1.5, 6, 12 and 24
hours. A group of normal animals was used as controls.
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Monoclonal antibodies
Mouse monoclonal antibodies used in this study were as
follows: 1A29 [27], an IgGl to rat ICAM-l (CD54); WT1[28], an
IgG2a to rat LFA-l a chain (CD! la); WT3 [28], an IgG 1 to rat
LFA-l/3 chain (CD18). All antibodies were supplied by Serotec
(Australian Laboratory Services, Melbourne, Australia).
Immunohistochemistry
Kidney for immunoperoxidase staining was immersion fixed
in periodate-lysine-paraformaldehyde (PLP) for two hours.
Serial 6 js cryostat sections were cut and stained as previously
described [2]. The mouse monoclonal antibodies were visual-
ized with a three layer immunoperoxidase technique using
peroxidase-conjugated goat anti-mouse IgG and mouse peroxi-
dase anti-peroxidase complexes followed by development with
3'3'-diaminobenzidine (DAB, Sigma Chemical Co., St. Louis,
Missouri, USA) and counterstaining with Harris' hemotoxylin.
Immunoelectronmicroscopy
The kidneys were perfusion fixed with PLP for five minutes
and then 1 mm thick slices were immersion fixed in PLP for two
hours. The slices were then immersed in increasing concentra-
tions of sucrose (5% up to 20%) in 0.1 M phosphate buffered
saline (PBS) pH 7.4 over 36 hours, and then placed in OCT and
snap frozen in liquid nitrogen. Subsequently 30 i cryostat
sections were cut and incubated in 5% normal goat serum
(NGS) in 0.01 M PBS, 0.8% bovine serum albumin (BSA) and
0.1% IGGS quality gelatin as a blocking step and then in the
primary monoclonal antibody overnight at 4°C. Monoclonal
antibodies were diluted 1 in 75 in 1% NGS in 0.01 M PBS/O.8%
BSA/0. 1% gelatin (dilution buffer). For each animal control
sections were incubated in dilution buffer only. Sections were
then incubated in goat antimouse IgG labeled with 1 nm gold
particles (Auroprobe One, Amersham Industries, Arlington
Heights, Illinois, USA) diluted 1 in 25 in dilution buffer.
Following extensive washing sections were fixed in 2% glutar-
aldehyde in PBS for 15 minutes and then silver enhanced using
IntenSE M kit (Amersham). Post-fixation with 1% aqueous
osmium for 30 minutes was followed by dehydration in graded
acetones and flat embedding of the sections in Epon-Araldite.
Sections 0.08 s thick were cut straight from the surface of the
block, mounted on copper grids, stained with lead citrate and
uranyl acetate and examined in a Philips CM12 electron micro-
scope.
Results
Immunohistochemistry
In normal animals ICAM- 1 (CD54) was constitutively weakly
expressed in glomeruli, in the interstitium and on some proxi- Fig. 1. (a) ICAM-1 (CD54) in normal. ICAM-1 is weakly expressed in
mal tubule brush borders (Fig. la). The tubulointerstitial the renal cortical interstitium, proximal tubule (PT) brush borders and
ICAM-1 expression was increased three- to fourfold as early as glomeruli (G). (b) ICAM-1 (CD54) in anti-GBM GN at 12 hours.
1.5 hours after initiation of anti-GBM GN and maintained at ICAM-1 expression is markedly increased as compared with normal in
similar intensity throughout the 24-hour time period. In addition the periglomerular interstitium (arrows) and on proximal tubule (PT)
brush borders. 0, glomerulus. (c) LFA-1/3 (CD18) in anti-GBM GN atttie percentage Oi i.vt-t positive tuoujes rncreaseu. tiiiS 12 hours. This plate represents a serial section to that stained with
up-regulation in tubulointerstitial ICAM-1 expression was more ICAM-1 in (b). The sites of CD18 positive leukocytes within the
marked in the periglomerular/perihilar regions and adjacent interstitium (arrows) correlate with those areas of most intense inter-
peritubular areas (Fig. ib). There was an associated interstitial stitial ICAM-l expression in (b). G, glomerulus. x200.
infiltration of LFA- 1 (CD1 la/CD 18) positive leukocytes in the
same areas as the increased ICAM-l expression as demon-
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Fig. 2. ICAM-1 (CD54) in anti-GBM GN at 6 hours. ICAM-l is present on the luminal surface only of a fenestrated interstitial capillary (arrows).
Note ICAM-l expression on the surface of an interstitial fibroblast-like cell (F). ICAM-l is absent from the basal surface of an adjacent proximal
convoluted tubule (PCT). C, capillary lumen. x 18,000.
strated in serial sections (Fig. 1 b and c), however, precise
localization of ICAM-l expression and sites of ICAM-l/LFA-l
interaction could not be identified.
Immunoelectronmicroscopy
Normal animals. Within the cortical tubulointerstitium,
staining for ICAM-1 (CD54) was present on the luminal surface
of the fenestrated endothelium of interstitial capillaries and the
endothelium of venules and arterioles and on the whole surface
of fibroblast-like interstitial cells. These fibroblast-like cells
were characterized by multiple long attenuated cell processes
and prominent profiles of granular endoplasmic reticulum and
Golgi apparatus. Sparse ICAM-l staining was detected on the
free surface of the parietal epithelium lining Bowman's capsule.
ICAM-l was sparsely present on proximal tubular brush bor-
ders but no staining was present on the lateral or basal surfaces
of these cells. Tubular cells of the distal nephron were negative.
Control sections were negative.
Occasional interstitial macrophages expressed surface LFA-l
(CDI la and CD18). Control sections were negative.
Anti-GBM disease. As early as 1.5 hours mononuclear leu-
kocytes, both macrophages and lymphocytes, were seen adher-
ent to capillary endothelium and had migrated into the intersti-
tium. This initial infiltrate was most prominent in the
periglomerular/perihilar regions. Subsequently mononuclear leu-
kocytic infiltration became more widespread over 6, 12 and 24
hours but was still most intense adjacent to glomeruli.
An increase in ICAM- 1 (CD54) staining on the endothelial
luminal surface of interstitial capillaries was apparent at 1.5
hours compared to normal and was further progressively in-
creased up to 24 hours; this was most marked in the periglom-
erular/perihilar regions (Fig. 2). Endothelial ICAM-1 expression
was particularly prominent at the sites of adhesion of "active-
appearing" mononuclear leukocytes (Fig. 3). These "active-
appearing" leukocytes were characterized by abundant cyto-
plasm with prominent Golgi apparatus, rough endoplasmic
reticulum and electron dense lysosomal-type granules. Adher-
ent leukocytes also expressed sparse surface ICAM-1 (Fig. 3).
In this disease model there was also up-regulation of ICAM- 1
expression by interstitial fibroblast-like cells compared to nor-
mal (Fig. 4a). Within the interstitium mononuclear leukocytes
were often seen in intimate contact with these fibroblast-like
cells with ICAM-1 expression prominent at such sites of contact
(Fig. 4b).
ICAM- 1 staining was also increased on proximal tubular cells
compared to normal, being localized exclusively to the brush
border (Fig. 5 a and b). ICAM-1 was not detected on the lateral
or basal surfaces of these cells or within coated pits on the
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Fig. 3. ICAM-1 (CD54) in anti-GBM GN at 6
hours. An "active-appearing" mononuclear
leukocyte, probably a macrophage (M), is
adherent to the endothelium of a
periglomerular interstitial capillary. ICAM-1 is
strongly expressed along the surface of the
capillary endothelium (asterisks) and is
present at the site of leukocyte adhesion
(arrow). ICAM-l is also more weakly and
irregularly expressed on the surface of the
leukocyte (arrowheads). Note ICAM-l
staining on the free surface of the glomerular
parietal epithelium at the bottom of the figure.
BC, Bowman's capsule. x 16,500.
brush border (Fig. 5 a and b). By 12 hours ICAM-l expression
was also present on the luminal surface of distal convoluted
tubules and collecting ducts. There was no evidence of leuko-
cytic adhesion to tubular cells. Control sections demonstrated
some nonspecific gold staining solely in protein reabsorption
droplets in proximal tubules.
In contrast to the relatively widespread expression of
ICAM- 1, LFA-1 (CD! la and CD1 8) staining was observed
solely on the surface of mononuclear leukocytes. Both CD1 la
and CD18 showed a similar pattern and intensity of expression
throughout the tubulointerstitium. The "active-appearing"
mononuclear leukocytes adherent to capillary endothelium
(both macrophages and lymphocytes) showed strong surface
expression of LFA- 1, particularly at the sites of adhesion (Figs.
6 and 7a). In contrast, nonadherent intracapillary leukocytes
showed little or no LFA-l expression (Fig. 7b). Cytoplasmic
vacuoles within adherent macrophages contained positive stain-
ing for LFA-1 (Fig. 6b). Mononuclear leukocytes were ob-
served migrating through the capillary walls and extending long
pseudopods within the interstitium. Such migrating leukocytes
showed strong LFA-1 expression along their entire surface
(Fig. 8a). Mononuclear leukocytes in close contact with inter-
stitial fibroblast-like cells also showed LFA-1 expression on
their cytoplasmic membranes, particularly at the sites of adhe-
sion between the leukocytes and the fibroblast-like cells (Fig.
8b). Control sections showed minimal nonspecific staining as
described for ICAM- 1.
Discussion
This is the first study to identify the ultrastructural localiza-
tion of ICAM-l expression in glomerulonephritis. The promi-
nent expression of ICAM-! and LFA-l antigens at sites of
adhesion between "active-appearing" leukocytes and intersti-
tial capillary endothelium is consistent with the ICAM-1/LFA-l
interaction playing a critical role in interstitial leukocytic infil-
tration in experimental anti-GBM GN (Nikolic-Paterson et al,
manuscript submitted). There was a clear up-regulation of
CD! la and CD18 antigens on the surface of these "active-
appearing" leukocytes compared to nonadherent circulating
cells. The role of LFA-l appears to be in strengthening adhe-
sion to activated endothelium following initial tethering involv-
ing selectins [28, 29]. LFA-l expression on the surface of
lymphocytes requires activation prior to mediating strong ad-
hesion [29, 30]. Both ICAM-1 and LFA-l expression are also
important in migration of mononuclear leukocytes through the
endothelium [31—33], and this would be consistent with our
observation that CD! la and CD18 are strongly expressed on the
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Fig. 4 (a) ICAM-1 (CD54) in anti-GBM GN at 6 hours. A
mononuclear leukocyte (L) with sparse surface ICAM-l expression is
adherent at several points (arrows) to an interstitial fibroblast-like cell
(F). The fibroblast-like cell shows strong surface expression of
ICAM-l including the sites of adhesion to the inflammatory
leukocyte. Note the absence of ICAM-l on the basal surface of the
adjacent proximal convoluted tubule (PCT). x16,500. (b) ICAM-l
(CD54) in anti-GBM GN at 12 hours. This lymphocyte (L) appears to
be tethered at several points to an interstitial fibroblast-like cell (F)
which expresses strong surface ICAM-l. Note the positive ICAM-l
staining present at each of these sites of adhesion (arrows). x 18,000.
entire surface of leukocytes migrating both through the endo-
thelium and within the interstitium. It is of interest that we
observed positive LFA- 1 staining within cytoplasmic vacuoles
in macrophages which could represent part of a secretory or
recycling pathway for LFA- 1.
An important finding was that once the LFA-1 expressing
leukocytes migrated into the renal interstitium, they localized
adjacent to, and demonstrated intimate contact with ICAM-l
expressing interstitial fibroblast-like cells. These fibroblast-like
cells probably represent both interstitial fibroblasts and den-
dritic cells which are difficult to distinguish solely on morpho-
logic criteria [341. This leukocyte/fibroblast-like cell interaction
could have two possible functions. Firstly, these cell to cell
contacts could be an important mechanism by which mononu-
clear leukocytes develop focal localization within the renal
interstitium. Secondly, such cell interactions could allow pre-
sentation of antigen to T lymphocytes. Such possibilities are
supported by studies demonstrating that ICAM-! expression on
the surface of cytokine stimulated dermal fibroblasts and
Langerhan's cells in vitro is responsible for the binding of
activated T lymphocytes [10, 35, 36], and that fibroblasts can
express MHC-class II antigens in response to cytokine stimu-
lation and are capable of acting as antigen presenting cells to T
lymphocytes [10, 37, 38]. In fact T lymphocyte proliferation in
response to cells bearing low levels of MHC-class II molecule
expression is greatly augmented by co-expression of ICAM-l
[38].
Previous studies of this disease model found that interstitial
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Fig. 5. ICAM-I (CD54) in anti-GBM GN at 24 hours. (a) ICAM-l
expression is confined to the brush border (asterisk) of the proximal
convoluted tubule (PCT). Note absence of staining on the lateral and
basal surfaces of the tubular cells (arrowheads). ICAM-l expression
is intense on the endothelial luminal surface of an adjacent interstitial
capillary (C, arrow). x 10,500. (b) At higher magnification ICAM-l is
seen confined to the surface of microvilli of the brush border but is
absent from the coated pits (asterisks). x25,000.
leukocytic infiltration was evident in the periglomerular hilar
region at 12 hours after administration of anti-GBM serum.
However, it was unclear whether these leukocytes had traf-
ficked from the glomerulus down the mesangial stalk to this area
or if this represented a separate though related infiltrate [2].
Using ultrastructural localization it is now evident that at least
part of this initial hilar infiltrate derives from leukocytes migrat-
ing out of periglomerular capillaries surrounding the hilar area.
No leukocytic migration out of larger vessels was evident,
suggesting that the initial "hilar arteriolar sheath" infiltrate [2]
reflects solely an initial localization of leukocytes from the
capillaries in that area.
The rapid and strong up-regulation of ICAM-1 expression in
the periglomerular hilar region, the adhesion of "active-appear-
ing" mononuclear leukocytes to nearby capillary endothelium,
and leukocytic accumulation in the hilar region supports the
postulate that in this disease cytokines are produced within the
glomerulus very rapidly following antibody deposition and
polymorphonuclear cell infiltration, and that such cytokines
(IL-i and TNF, for example) may diffuse down the mesangial
stalk or via the efferent glomerular circulation to the hilar area
and induce leukocytic infiltration [1, 3, 4, 39]. This postulate is
further supported by the suppression of ICAM- 1 expression and
interstitial leukocyte infiltration by IL-i receptor antagonist
treatment in this disease model [40, Nikolic-Paterson et al,
manuscript submitted]. We have demonstrated by immunogold
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Fig. 6. LFA-1 /3(CDJ8) in anli-GBM GN at 6 hours. (a) An adherent "active-appearing" mononuclear leukocyte, probably a macrophage (M),
shows strong surface expression of CDI 8, particularly at the sites of adhesion to the endothelium of an interstitial capillary (arrows). Note absence
of any staining of endothelium or interstitial fibroblast-like cells (F). C, capillary lumen x 17,500. (b) At higher magnification CD18 is seen fairly
evenly distributed on the surface of this macrophage (M) adherent to the interstitial capillary endothelium (E). Note that CD18 is concentrated at
the points of leukocyte adhesion (arrows) and is also present within cytoplasmic vacuoles (asterisks). C, capillary lumen. X33,000.
electron microscopic localization that rabbit anti-rat GBM
antibody in this model is localized exclusively to the glomerular
basement membrane and is not detectable within the tubuloin-
terstitium in basement membranes surrounding Bowman's cap-
sule, tubules or interstitial capillaries (Hill, unpublished obser-
vations). These findings, together with the absence of PMNL as
a component of the interstitial leukocytic infiltrate suggest that
interstitial heterologous antibody deposition and complement
activation do not play an important role in the interstitial
leukocytic accumulation in this disease.
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Fig. 7. LFA-1 a(CDIIa) in anti-GBM GN at
12 hours. (a) Note the similar pattern and
intensity of the staining of CD! la on the
surface of this leukocyte to that of CD18 in
Fig. 6a. This "active-appearing" mononuclear
leukocyte, probably a macrophage, is
adherent to the endothelium of an interstitial
capillary (C) in the periglomerular hilar
region. G, glomerulus; BC, Bowman's
capsule. x 10,500. (b) This nonadherent
intracapillary mononuclear leukocyte,
probably a lymphocyte (L), shows only very
sparse surface CD! la as compared with the
strong pattern of staining on the adherent
leukocyte in Fig. 7a. C, peritubular capillary
lumen; PCT, proximal convoluted tubule.
x 10,500.
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Fig. 8. LFA-J$ (CD 13) in anti-GBM GN at 6 hours. (a) Within the interstitium a migrating mononuclear leukocyte, probably a lymphocyte (L),
expresses strong surface CD 18. The leukocyte is extending a long pseudopod (arrow) and its surface is in intimnte contact at several points with
interstitial fibroblast-like cells (F). C, interstitial capillary lumen; PCT, proximal convoluted tubule. x 14,000. (b) CD18 is strongly expressed on
the surface of this mononuclear leukocyte, prohably a lymphocyte (L), which shows a large area of contact with an interstitial fibroblast-like cell
(F). Note CD18 is present on the leukocyte at the site of adhesion (arrows) but is not seen on the surface of the fibroblast-like cell. x20,000.
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The role of increased tubular ICAM-1 expression in the
initiation and progression of tubulointerstitial injury is not clear.
Proximal tubular brush border expression of ICAM-l, which is
only very weak in normal kidneys, has been shown to be
up-regulated in glomerulonephritis and graft rejection [17—21,
25, 26, 41—43]. This was associated with increased tubular
basolateral MHC-class II antigen expression, and it has been
postulated that the tubular cell may act as an antigen presenting
cell promoting tubular immune damage 121, 25, 41—43]. In this
study we confirmed that ICAM- 1 is confined to the luminal
microvillous surface of proximal tubules and is not detectable
on the lateral or basal surfaces of these cells. In addition, by 12
hours we demonstrated de nova expression of ICAM-1 on the
luminal surface of distal tubules and collecting ducts. The solely
luminal localization of tubular ICAM-l expression raises the
possibility that it may be due to nonspecific reabsorption of
ICAM-l filtered through a leaky glomerular barrier. The lack of
evidence of leukocytic adhesion to tubular cells suggests that
during this initial phase of disease, up-regulation of tubular
ICAM-! expression plays no major role in interstitial leukocytic
infiltration or localization.
We conclude that ICAM-1 and LFA-1 play a role in the early
development of the tubulointerstitial inflammatory infiltrate in
experimental anti-GBM GN in the rat by (I) promoting the
adhesion of mononuclear leukocytes within the interstitial
capillary bed, particularly in the periglomerular/perihilar re-
gion, and their subsequent migration into the interstitium, and
(2) by promoting interstitial localization of mononuclear leuko-
cytes and their interaction with potentially antigen-presenting
interstitial fibroblast-like cells. The solely luminal localization
of tubular ICAM-l expression throws into doubt the importance
of tubular ICAM-1 in the development and progression of
tubulointerstitial inflammation in the early stages of GN.
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